Your browser doesn't support javascript.
loading
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Murray Brunt, Adrian; Haviland, Joanne S; Wheatley, Duncan A; Sydenham, Mark A; Alhasso, Abdulla; Bloomfield, David J; Chan, Charlie; Churn, Mark; Cleator, Susan; Coles, Charlotte E; Goodman, Andrew; Harnett, Adrian; Hopwood, Penelope; Kirby, Anna M; Kirwan, Cliona C; Morris, Carolyn; Nabi, Zohal; Sawyer, Elinor; Somaiah, Navita; Stones, Liba; Syndikus, Isabel; Bliss, Judith M; Yarnold, John R.
Afiliação
  • Murray Brunt A; University Hospitals of North Midlands and University of Keele, Stoke on Trent, UK; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK. Electronic address: fastforward-icrctsu@icr.ac.uk.
  • Haviland JS; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK.
  • Wheatley DA; Royal Cornwall Hospital, Treliske, Truro, UK.
  • Sydenham MA; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK.
  • Alhasso A; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Bloomfield DJ; Brighton and Sussex University Hospitals, Brighton, UK.
  • Chan C; Nuffield Health Cheltenham Hospital, Cheltenham, UK.
  • Churn M; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Cleator S; Imperial Healthcare NHS Trust, London, UK.
  • Coles CE; University of Cambridge, Cambridge, UK.
  • Goodman A; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; Torbay Hospital NHS Foundation Trust, Torquay, UK.
  • Harnett A; Norfolk and Norwich University Hospital, Norwich, UK.
  • Hopwood P; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK.
  • Kirby AM; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
  • Kirwan CC; University of Manchester, Manchester, UK.
  • Morris C; Independent Cancer Patients' Voice, London, UK.
  • Nabi Z; Mount Vernon Cancer Centre, Northwood, UK.
  • Sawyer E; King's College London, London, UK.
  • Somaiah N; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
  • Stones L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK.
  • Syndikus I; Clatterbridge Cancer Centre, Bebington, Wirral, UK.
  • Bliss JM; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, London, UK.
  • Yarnold JR; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Lancet ; 395(10237): 1613-1626, 2020 05 23.
Article em En | MEDLINE | ID: mdl-32580883
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article